Product Information
Name:FRAX1036
Brand:Biosynth
Description:FRAX1036 is a new molecule which inhibits the cancer-promoting activity of epidermal growth factor (EGF). FRAX1036 was shown to block the signaling pathways downstream of EGFR, including MAPK and β-catenin. This drug also synergistically inhibited tumor growth in mice with xenografts of human prostate cancer cells. FRAX1036 has been shown to be effective when combined with taxane treatment, which is an anticancer drug that inhibits the cell division cycle by blocking microtubule assembly.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:518.05 g/mol
Formula:C28H32ClN7O
Purity:Min. 95%
Technical inquiry about: FRAX1036
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.